FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170740805> ?p ?o ?g. }

• W2170740805 endingPage "1317" @default.
• W2170740805 startingPage "1306" @default.
• W2170740805 abstract "BACKGROUND Treatment of hepatitis C with peginterferon and ribavirin is associated with psychiatric side-effects, frequently necessitating dose reduction or therapy cessation. AIM To assess the efficacy of prophylactic escitalopram to prevent psychiatric side-effects during peginterferon and ribavirin treatment in a randomised, double-blind, placebo-controlled trial. METHODS Seventy-nine hepatitis C patients were treated with peginterferon and ribavirin. Patients received escitalopram (n = 40, 10 mg) or placebo (n = 39), which was initiated together with peginterferon and ribavirin. Primary outcomes were an increase of two points or more on the items reported sadness, inner tension and impaired concentration of the Montgomery-Asberg Depression Rating Scale, and hostile feelings of the Brief Anxiety Scale. Secondary outcome was the development of depression diagnosed by the Mini-International Neuropsychiatric Interview. Measurements were performed at baseline, week 4, 12 and 24 during anti-viral treatment, and 24 weeks thereafter. RESULTS The incidence of psychiatric side-effects was significantly lower in patients treated with escitalopram compared with placebo for all primary and secondary outcomes, except for impaired concentration: reported sadness 27.5 vs. 48.7% (P = 0.052), inner tension 17.5 vs. 38.5% (P = 0.038), impaired concentration 55.0 vs. 66.7% (P = 0.288) and hostile feelings 22.5 vs. 43.6% (P = 0.046) (escitalopram vs. placebo, Chi-squared test). The sum scores of all four endpoints showed an overall beneficial effect of escitalopram (P = 0.009, Mann-Whitney U-test). Depression occurred in 12.5% of the patients in the escitalopram-group vs. 35.9% in the placebo-group (P = 0.015, Chi-squared test). CONCLUSIONS Prophylactic treatment with escitalopram is effective in the prevention of psychiatric side-effects during interferon-based treatment of hepatitis C." @default.
• W2170740805 created "2016-06-24" @default.
• W2170740805 creator A5003213570 @default.
• W2170740805 creator A5010550239 @default.
• W2170740805 creator A5016596524 @default.
• W2170740805 creator A5018450847 @default.
• W2170740805 creator A5029652421 @default.
• W2170740805 creator A5031051209 @default.
• W2170740805 creator A5064015662 @default.
• W2170740805 creator A5072837175 @default.
• W2170740805 creator A5084952188 @default.
• W2170740805 date "2011-10-17" @default.
• W2170740805 modified "2023-10-18" @default.
• W2170740805 title "Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C" @default.
• W2170740805 cites W1482765914 @default.
• W2170740805 cites W1517770332 @default.
• W2170740805 cites W1925910633 @default.
• W2170740805 cites W1969178220 @default.
• W2170740805 cites W1975882081 @default.
• W2170740805 cites W1978339383 @default.
• W2170740805 cites W1992692012 @default.
• W2170740805 cites W1992790530 @default.
• W2170740805 cites W1995596015 @default.
• W2170740805 cites W1998976706 @default.
• W2170740805 cites W2027540914 @default.
• W2170740805 cites W2027545702 @default.
• W2170740805 cites W2033746593 @default.
• W2170740805 cites W2044339064 @default.
• W2170740805 cites W2055485744 @default.
• W2170740805 cites W2058750823 @default.
• W2170740805 cites W2059918917 @default.
• W2170740805 cites W2067855438 @default.
• W2170740805 cites W2072833030 @default.
• W2170740805 cites W2073606662 @default.
• W2170740805 cites W2091341212 @default.
• W2170740805 cites W2098721408 @default.
• W2170740805 cites W2102280593 @default.
• W2170740805 cites W2107044757 @default.
• W2170740805 cites W2112876622 @default.
• W2170740805 cites W2127685726 @default.
• W2170740805 cites W2128482064 @default.
• W2170740805 cites W2131823335 @default.
• W2170740805 cites W2141559815 @default.
• W2170740805 cites W2145508080 @default.
• W2170740805 cites W2333452860 @default.
• W2170740805 cites W2338816059 @default.
• W2170740805 cites W4249162025 @default.
• W2170740805 doi "https://doi.org/10.1111/j.1365-2036.2011.04867.x" @default.
• W2170740805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21999489" @default.
• W2170740805 hasPublicationYear "2011" @default.
• W2170740805 type Work @default.
• W2170740805 sameAs 2170740805 @default.
• W2170740805 citedByCount "39" @default.
• W2170740805 countsByYear W21707408052012 @default.
• W2170740805 countsByYear W21707408052013 @default.
• W2170740805 countsByYear W21707408052014 @default.
• W2170740805 countsByYear W21707408052015 @default.
• W2170740805 countsByYear W21707408052016 @default.
• W2170740805 countsByYear W21707408052017 @default.
• W2170740805 countsByYear W21707408052018 @default.
• W2170740805 countsByYear W21707408052019 @default.
• W2170740805 countsByYear W21707408052020 @default.
• W2170740805 countsByYear W21707408052022 @default.
• W2170740805 countsByYear W21707408052023 @default.
• W2170740805 crossrefType "journal-article" @default.
• W2170740805 hasAuthorship W2170740805A5003213570 @default.
• W2170740805 hasAuthorship W2170740805A5010550239 @default.
• W2170740805 hasAuthorship W2170740805A5016596524 @default.
• W2170740805 hasAuthorship W2170740805A5018450847 @default.
• W2170740805 hasAuthorship W2170740805A5029652421 @default.
• W2170740805 hasAuthorship W2170740805A5031051209 @default.
• W2170740805 hasAuthorship W2170740805A5064015662 @default.
• W2170740805 hasAuthorship W2170740805A5072837175 @default.
• W2170740805 hasAuthorship W2170740805A5084952188 @default.
• W2170740805 hasBestOaLocation W21707408051 @default.
• W2170740805 hasConcept C118552586 @default.
• W2170740805 hasConcept C126322002 @default.
• W2170740805 hasConcept C139719470 @default.
• W2170740805 hasConcept C142724271 @default.
• W2170740805 hasConcept C162324750 @default.
• W2170740805 hasConcept C168563851 @default.
• W2170740805 hasConcept C197934379 @default.
• W2170740805 hasConcept C203014093 @default.
• W2170740805 hasConcept C204787440 @default.
• W2170740805 hasConcept C2522874641 @default.
• W2170740805 hasConcept C27081682 @default.
• W2170740805 hasConcept C2776408679 @default.
• W2170740805 hasConcept C2776412080 @default.
• W2170740805 hasConcept C2776455275 @default.
• W2170740805 hasConcept C2776867660 @default.
• W2170740805 hasConcept C2779177272 @default.
• W2170740805 hasConcept C2779583969 @default.
• W2170740805 hasConcept C2780040827 @default.
• W2170740805 hasConcept C2780634440 @default.
• W2170740805 hasConcept C558461103 @default.
• W2170740805 hasConcept C71924100 @default.
• W2170740805 hasConcept C90924648 @default.
• W2170740805 hasConceptScore W2170740805C118552586 @default.

• next